Long‐Term Effects of Sglt2 Deletion on Bone and Mineral Metabolism in Mice
ABSTRACT Sodium‐glucose cotransporter 2 (SGLT2) inhibitors improve kidney and cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM). However, bone fragility has emerged as a side effect in some but not in all human studies. Because use of SGLT2 inhibitors in humans affects mineral...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2021-08-01
|
| Colección: | JBMR Plus |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1002/jbm4.10526 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|